Albemarle (ALB) Rises As Market Takes a Dip: Key Facts

Group 1 - Albemarle's stock closed at $77.07, reflecting a +1.76% change, outperforming the S&P 500's daily loss of 0.01% [1] - Over the past month, Albemarle's shares have appreciated by 27.51%, significantly exceeding the Basic Materials sector's gain of 1.67% and the S&P 500's gain of 5.37% [1] Group 2 - Albemarle is set to release its earnings report on July 30, 2025, with projected earnings of -$0.83 per share, indicating a year-over-year decline of 2175% [2] - The consensus estimate for revenue is $1.23 billion, down 13.67% from the prior-year quarter [2] Group 3 - For the full year, analysts expect earnings of -$2.02 per share and revenue of $4.86 billion, representing changes of +13.68% and -9.54% respectively from last year [3] Group 4 - Recent changes to analyst estimates for Albemarle reflect evolving short-term business trends, with positive revisions indicating a favorable outlook on business health and profitability [4] Group 5 - The Zacks Rank system, which assesses estimated changes, currently ranks Albemarle as 4 (Sell), with the consensus EPS estimate having moved 24.78% lower over the past month [6] Group 6 - The Chemical - Diversified industry, part of the Basic Materials sector, holds a Zacks Industry Rank of 228, placing it in the bottom 8% of over 250 industries [7]